Shellard, S A <br/><br/>
Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines.  [electronic resource] 

 -  Anti-cancer drugs  Aug 1993 
 - 491-500 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-199308000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Carcinoma, Small Cell--drug therapy<br/>Catalase--metabolism<br/>Cisplatin--metabolism<br/>DNA--metabolism<br/>DNA Adducts<br/>DNA Damage<br/>DNA Repair<br/>DNA, Neoplasm--drug effects<br/>Drug Resistance<br/>Drug Screening Assays, Antitumor<br/>Gene Expression<br/>Glutathione--metabolism<br/>Glutathione Peroxidase--metabolism<br/>Glutathione Reductase--metabolism<br/>Glutathione Transferase--metabolism<br/>Humans<br/>Kinetics<br/>Lung Neoplasms--drug therapy<br/>Metallothionein--genetics<br/>NAD(P)H Dehydrogenase (Quinone)--metabolism<br/>Tumor Cells, Cultured